US3528976A - Process for the preparation of substituted oxazolidones - Google Patents

Process for the preparation of substituted oxazolidones Download PDF

Info

Publication number
US3528976A
US3528976A US566214A US3528976DA US3528976A US 3528976 A US3528976 A US 3528976A US 566214 A US566214 A US 566214A US 3528976D A US3528976D A US 3528976DA US 3528976 A US3528976 A US 3528976A
Authority
US
United States
Prior art keywords
reaction
carbon atoms
epoxide
oxazolidone
percent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US566214A
Inventor
Manfred Budnowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1076965A external-priority patent/CH475242A/en
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Application granted granted Critical
Publication of US3528976A publication Critical patent/US3528976A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
    • C07D203/10—Radicals substituted by singly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/104—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/108—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/59—Hydrogenated pyridine rings

Definitions

  • R and R are selected from the group consisting of organic groups free from epoxide-reacting s'ubstituents and, taken together, a bridging organic linkage free from epoxide-reacting substituents, said R and R having a total of from 2 to 30 carbon atoms.
  • a further object of the present invention is the devel- 3,528,976 Patented Sept. 15, 1970 opment of a process for the preparation of a S-substituted oxazolidone of the formula wherein R and R are selected from the group consisting of organic groups free from epoxide-reacting substituents and, taken together, a bridging organic linkage free form epoxide-reacting substituents, said R and R having a total of from 2 to 30 carbon atoms, which comprises reacting triglycidyl isocyanurate with a compound of the formula wherein R and R have the above-assigned meanings, at a temperature between about 60 C. and about 240 C and recovering said 5-substituted oxazolidone.
  • Suitable organic nitrogen compounds having a hydrogen atom on the nitrogen atom capable of reacting with epoxide compounds are, for example, secondary amines of the general formula R2 wherein R and R can be identical or different, if desired substituted, aliphatic, cycloaliphatic, aromatic hydrocarbon radicals or heterocyclic radicals. These compounds can contain as substitutents those which are able to react, not at all, or only slowly with the epoxide group under the reaction condition conditions.
  • Such secondary amines may be: dialkylamines, such as dimethylamine, diethylamine, dibutylamine, ethyl-propylamine, dioctylamine, dodecylmethylamine, methylisopropylamine; alkylcycloalkylamines such as cyclohexylmethylamine; dicycloalkylamines such as dicyclohexylamine; diphenylamine; alkylheterocyclicamines such as methyltetrahydrofurfurylamine; dialkanol amines such as diethanolamine; alkylphenylamines such as methylaniline, N-ethyl- N-p-methoxyphenylamine, N-ethyl-p-chloroaniline, N- methyl-N-p-nitrophenylamine, etc.
  • dialkylamines such as dimethylamine, diethylamine, dibutylamine, ethyl-propylamine
  • R and R can be selected from the group consisting of alkyl having from 1 to 18 carbon atoms, alkenyl having from 3 to 18 carbon atoms, hydroxyalkyl having from 2 to 18 carbon atoms, phenyl, halophenyl, lower alkoxyphenyl, nitrophenyl, and tetrahydrofurfuryl.
  • Suitable organic nitrogen starting materials are, for example heterocyclic nitrogen compounds having a replaceable hydrogen atom on the nitrogen atom such as pyrrole, pyrroline, pyrrolidine, pyrazole, imidazole, the triazoles, benzimidazole, indole, piperidine, morpholine, theophylline, nornicotene and their derivatives.
  • R and R are taken together and represent an organic bridging linkage.
  • the compounds react essentially as secondary amines. These compounds can likewise carry substituents, which under the reaction conditions in contact with epoxide compounds, are inactive or substantially less active than the replaceable hydrogen atom intended for the reaction.
  • Suitable starting materials are, for example, straight-chain and cyclic sulfonic acid amides or carboxylic acid amides, which contain one reactive hydrogen atom on the nitrogen atom.
  • be ong compounds such as p-toluene sulfonic acid methylamide, p-toluene sulfonic acid anilide, p-toluene sulfonic acid dodecylamide, p-toluene sulfonic acid oleylamide, 4- acetamido-benzene-sulfonic acid methylamide, p-acetamido benzene sulfonic acid-N-thiazolylamide, p-nitroacetanilide, p chloroacetanilide, N acetyl-p-toluidine, acetophenetidine, also sultams and lactams.
  • R can be selected from the group consisting of alkyl having from 1 to 18 carbon atoms, alkenyl having from 3 to 18 carbon atoms, alkanol having from 2 to 18 carbon atoms, phenyl, halophenyl, lower alkoxyphenyl, nitrophenyl, tetrahydrofurfuryl and thiazolyl; while R can be selected from the group consisting of the acyl of an organic carboxylic acid having from 2 to 18 carbon atoms and the acyl of an organic sulfonic acid having from 2 to 18 carbon atoms.
  • the named and similar compounds may, in turn, carry any other substituents, which, under the reaction conditions, do not react at all or only slowly with epoxide compounds.
  • straight-chain or cyclic imides such as carboxylic acid-, sulfonic acidor mixed imides are to be considered as, for example, succinimide, phthalimide, maleic acid imide, o-sulfobenzoic acid imide (saccharin); disulfimides such as bis-(p-toluenesulfonyl)-imide, also hydantoin, 5,5-diphenyl-imidazolidine-dione-(2,4), theobromine, and their derivatives. These compounds too can carry substituents, which under the prevailing reaction conditions are either inactive or only slightly active with respect to epoxide compounds.
  • the triglycidyl isocyanurate also serving as starting material, can be obtained, according to the processes described in the copending, comonly-assigned US. patent applications Ser. No. 288,593, filed June 18, 1963, now Pat. No. 3,288,789, or Ser. No. 467,140, filed June 25, 1965, now Pat. No. 3,300,490, in a simple manner in pure crystallized form from cyanuric acid and epichlorohydrin.
  • Triglycidyl isocyanurate exists in two diastereomeric forms with difierent melting points (106 C. and 158 C.). Both forms can be employed either each by itself or admixed with each other for the present reaction.
  • the reaction is effected in that for each one mol of the triglycidyl isocyanurate, three mols of the respective, nitrogen containing compound are reacted. Consequently, it is of advantage to use the reactants at a ratio of about 1:3.
  • the nitrogen containing compound can also be used in excess, advantageously up to about 6 mols to each mol of triglycidyl isocyanurate. This is particularly advantageous, when the nitrogen containing compound is easily volatile, so that the excess can be removed in a simple manner. It is less advisable to use the nitrogen containing compound in deficiency, because, as a rule,
  • the reaction according to the present invention is carried out in an organic solvent.
  • organic solvent Suitable are, for example, benzene, toluene, chlorobenzene, dimethylformamide, dimethylsulfoxide, acetone and the like. It was noted that the reaction proceeds faster in polar solvents than in non-polar solvents. However, if the work is carried out with an excess of a basic nitrogen containing compound, no particular consideration is called for in regard to the choice of solvents.
  • Suitable bases are, for example, alkali metal hydroxides such as sodium hydroxide and potassium hydroxide; alkali metal lower alkylates such as sodium methylate and sodium ethylate; or tertiary organic bases such as dimethylaniline or dimethylbenzylamine. These compounds are active in relatively small amounts. In general, an addition of 0.001 to 0.1 equivalent of the bases indicated per one mol of the nitrogen containing compound will be sufiicient.
  • the triglycidyl isocyanurate and the nitrogen containing compound are dissolved in a suitable Organic solvent, and the reaction mixture, if so desired after adding a small amount of a base, is heated until the epoxideoxygen content of the solution has dropped to zero.
  • the reaction temperature may fluctuate within broad limits, for example, between about 60 C. and 240 C. In many cases it is advantageous to conduct the reaction under the reflux temperature of the organic solvent employed.
  • the reaction may even be accomplished without any solvents.
  • it can be of advantage to add the triglycidyl socyanurate gradually to the dissolved nitrogen containing reactant heated to higher temperatures, as in this way a polymerization of the epoxide can be prevented.
  • the solvent can be, if so desired, distilled off substantially under decreased pressure.
  • the residue resulting from the evaporation is crystallized with suitable solvents such as alcohol, ether, water and others and, if necessaryy, recrystallized therefrom.
  • suitable solvents such as alcohol, ether, water and others and, if necessaryy, recrystallized therefrom.
  • an intermediate step can be established 1n the reaction and the cyanurate reaction product converted into the desired oxazolidone in a second operation step. However, in many cases the reaction proceeds so rapidly that the intermediate cannot be isolated.
  • Example 1 15 gm. of the high-melting (,B-form) cyanurate and 20 gm. of diethylamine were stirred together with 200 ml. of nitrobenzene and 0.5 gm. of potassium hydroxide for 5 hours at 150 C. After this period no epoxide-oxygen content was evident any more. Next, the solvent was distilled under decreased pressure. The residue was several times recrystallized from benzin (B.P. C. to C.) with an addition of about 5% of ether. The yield of S-(diethylaminomethyl)-oxazolidone-(2), after five recrystallizations, amounted to 14 gm. (67% of the theory). The product had a melting point of about 70 C.
  • Example 2 29.7 gm. of the high-melting (B-form) of triglycidyl isocyanurate and 64.2 gm. of methylaniline were stirred together with 400 ml. of nitrobenzene and 0.5 gm. of sodium hydroxide over a period of hours at 150 C. After this time, no epoxide-oxy-gen content was evident anymore. Then the solvent was distilled therefrom under decreased pressure. The resultant residue consisted of a viscous syrup, the oxazolidone structure of which was determined by infra-red-analysis. A sample of 20 gm. was recrystallized five times from an ether/petroleum ether mixture. The melting point of the thus purified 5- [(N-methyl-N-phenyl) -aminomethyl] oxazolidone (2) was 73 C. The yield amounted to 12 gm. corresponding with 59% of the theory.
  • Example 3 30 gm. of the high-melting (p-form) of triglycidyl isocyanurate were heated together with 81 gm. of pnitroacetanilide and 300 ml. of dimethylforamide to 140 C. while stirring. 0.5 gm. of sodium hydroxide were added to the mixture. After a reaction period of 4 hours at 140 C., the epoxide-oxygen content of the solution had dropped to zero. After being cooled to room temperature, the solvent was distilled therefrom, to a great extent, under decreased pressure. The resultant residue (111 gm.) was extracted twice with water. After concentration of the aqueous phase, a residue remained, which was recrystallized twice from ethanol.
  • Example 4 29.7 gm. of the low-melting (or-form) of triglycidyl isocyanurate and 44.5 gm. of phthalimide were heated together with 400 ml. of chlorobenzene and 200 mg. of sodium hydroxide at reflux for 1% hours. After this period no epoxide-oxygen content was evident anymore. Subsequently, most of the solvent was distilled 01f at decreased pressure. The residue was recrystallized from a water/ethanol mixture (1:1). 65 gm., that is 88% of theory, of S-(phthalimidomethyl)-oxazolidone-(2) were obtained, the product having a melting point of 184 C.
  • Example '5 29.7 gm. of the high-melting (fit-form) of triglycidyl isocyanurate and 5 6 gm. of p-toluenesulfonic acid methylamide were heated, together with 500 ml. of toluene and 300 mg. of pulverized sodium hydroxide, at reflux for 5 hours. After this period, the epoxide-oxygen content of the solution had dropped to zero. Then most of the solvent was distilled off under decreased pressure (water-jet pump). The residue was recrystallized from benezene. 70 gm. (that is 82% of theory) of N-methyl- N [(oxazolidone-(2)-yl-(5))-methyl] p toluene-sulfonamide were obtained. The product had a melting point of 121 C.
  • Example 6 29.7 gm. of the high-melting (pr-form) of triglycidyl isocyanurate and 55 gm. of saccharin (2,3-dihydro-3- oxobenzisosulfonazole) were heated, together with one liter of chlorobenzene and 300 mg. of sodium hydroxide, at reflux. After 14 hours the epoxide-oxygen content of the solution had dropped to zero. Thereafter, most of the solvent was distilled off under decreased pressure, the residue was taken up in chloroform and precipitated with ether.
  • Example 7 29.7 gm. of the low-melting (ct-form) of triglycidyl isocyanurate and 28 gm. of piperidine were heated, together with 350 m1. of toluene and 250 mg. of sodium hydroxide for 1 hour at reflux. After this time the epoxideoxygen content had dropped to zero. The purification of the mixture was effected by recrystallization of the evaporation residue from ethyl acetate.
  • Example 8 29.7 gm. of the low-melting (or-form) of triglycidyl isocyanurate and 27 gm. of morpholine were heated, together with 350 ml. of toluene and 250 mg. of sodium hydroxide, at reflux for 1 hour. After this period of time no epoxide-oxygen content was evident anymore. The purification of the mixture was effected by a single recrystallization of the precipitation product from toluene. The yield of 5 morpholinomethyl oxazolidone (2) amounted to 52 gm. (92% of the theory). The product had a melting point of 124 C.
  • Example 9 This example proves that it is often possible to isolate the adduct formed in the first step by means of reaction of the nitrogen containing compound with triglycidyl isocyanurate, and then, in a second step to effect the cyclization to oxazolidone with the addition of a base.
  • This isocyanurate was again heated, in a second reaction stage, at reflux for 10 hours in 300 ml. of toluene, in the presence of 30 mg. of sodium hydroxide. After the reaction mixture had been cooled, the crystallized 5- morpholino-methyl-oxazolidone-(2) was filtered and re crystallized from benzene.
  • the product which was identical to the one obtained by the process described in Example 8, had a melting point of 124 C. The yield amounted to 43 gm. of product (75% of the theory).
  • Example 10 29.7 gm. of the high-melting (ii-form) of triglycidyl isocyanurate and 50.0 gm. of di-n-butylamine were heated together with 500 ml. of chlorobenzene 500 mg. of sodium hydroxide at reflux for 7 hours. After this period no epoxide-oxygen content was evident anymore. After being cooled to room temperature the reaction solution was filtered and the solvent was distilled therefrom under decreased pressure. The residue was crude S-(di-n-butylaminomethyl)-oxaZolidone-(2) in a yield of 59 gm. (86% of the theory). After distillation under decreased pressure the yield of the pure product amounted to 51 gm.
  • the products obtained according to the process of the invention are valuable pharmaceutics.
  • the invention process renders it possible to combine the pharmacologically active oxazolidone group in a very careful way with other pharmacologically active groups, for example with the sulfonamide groups to obtain the combined pharmacological eifectiveness of both active groups.
  • oxazolidones can be prepared from those reactants, which are thermically sensitive as for example morpholine, and for which other oxazolidone syntheses fail for this very reason.
  • the products produced are useful as sedatives and muscular relaxants, in general at low dosages.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

United States Patent Oifice 3,528,976 PROCESS FOR THE PREPARATION OF SUBSTITUTED OXAZOLIDONES Manfred Budnowski, Dusseldorf-Holthausen, Germany,
assignor to Henkel & Cie, G.m.b.H., Dusseldorf-Holthausen, Germany, a corporation of Germany No Drawing. Filed July 19, 1966, Ser. No. 566,214 Claims priority, application Germany, June 24, 1966, H 59,753 Int. Cl. C07d 85/28, 87/40 [1.5. Cl. 260247.2 14 Claims ABSTRACT OF THE DISCLOSURE The present invention relates to novel oxazo idones- (2) substituted in the 5 position of the formula wherein R and R have the above-assigned meanings.
CLAIM FOR PRIORITY Applicant hereby claims the right of priority under 35 U.S.C. 119, based on the corresponding German application H 59,753, filed June 24, 1966.
THE PRIOR ART It is common knowledge, that S-substituted oxazolidomes-(2), for example S-(aryloxymethyl)-oxazolidones- (2) represent valuable sedatives and muscle relaxants. Various processes are known for the preparation of these oxazolidones. For the production of 5-(aryloxymethyl)- oxazolidones-(Z), for example the reaction of the corresponding phenylglycidylether with urea is well known. Analogous to this method of preparation it was to be anticipated, that glycidyl derivatives of secondary amines would yield also oxazolidones by reaction with urea. However, an attempt to react N-glycidylmorpholine with urea showed, that not the desired oxazolidones resulted, instead the reaction gave poylmer products, wherein no oxazolidone structures were observed by means of infrared spectroscopy. Consequently, this method for the preparation of the desired produtcs was rejected.
OBJECTS OF THE INVENTION wherein R and R are selected from the group consisting of organic groups free from epoxide-reacting s'ubstituents and, taken together, a bridging organic linkage free from epoxide-reacting substituents, said R and R having a total of from 2 to 30 carbon atoms.
A further object of the present invention is the devel- 3,528,976 Patented Sept. 15, 1970 opment of a process for the preparation of a S-substituted oxazolidone of the formula wherein R and R are selected from the group consisting of organic groups free from epoxide-reacting substituents and, taken together, a bridging organic linkage free form epoxide-reacting substituents, said R and R having a total of from 2 to 30 carbon atoms, which comprises reacting triglycidyl isocyanurate with a compound of the formula wherein R and R have the above-assigned meanings, at a temperature between about 60 C. and about 240 C and recovering said 5-substituted oxazolidone.
DESCRIPTION OF THE INVENTION These and other objects of the invention will become more apparent as the description thereof proceeds.
Now it has been discovered, that 5-substituted oxazolidones-(Z) can be obtained, when triglycidyl isocyanurate is reacted at elevated temperatures with an organic nitrogen compound, which contains on the nitrogen atom a hydrogen atom capable of reacting with epoxide compounds.
Utilizing as starting material, for example a secondary amine, the reaction of the invention proceeds according to the following over-all formula:
Suitable organic nitrogen compounds having a hydrogen atom on the nitrogen atom capable of reacting with epoxide compounds are, for example, secondary amines of the general formula R2 wherein R and R can be identical or different, if desired substituted, aliphatic, cycloaliphatic, aromatic hydrocarbon radicals or heterocyclic radicals. These compounds can contain as substitutents those which are able to react, not at all, or only slowly with the epoxide group under the reaction condition conditions. Such secondary amines may be: dialkylamines, such as dimethylamine, diethylamine, dibutylamine, ethyl-propylamine, dioctylamine, dodecylmethylamine, methylisopropylamine; alkylcycloalkylamines such as cyclohexylmethylamine; dicycloalkylamines such as dicyclohexylamine; diphenylamine; alkylheterocyclicamines such as methyltetrahydrofurfurylamine; dialkanol amines such as diethanolamine; alkylphenylamines such as methylaniline, N-ethyl- N-p-methoxyphenylamine, N-ethyl-p-chloroaniline, N- methyl-N-p-nitrophenylamine, etc. In the above basic formula for secondary amines, R and R can be selected from the group consisting of alkyl having from 1 to 18 carbon atoms, alkenyl having from 3 to 18 carbon atoms, hydroxyalkyl having from 2 to 18 carbon atoms, phenyl, halophenyl, lower alkoxyphenyl, nitrophenyl, and tetrahydrofurfuryl.
Other suitable organic nitrogen starting materials are, for example heterocyclic nitrogen compounds having a replaceable hydrogen atom on the nitrogen atom such as pyrrole, pyrroline, pyrrolidine, pyrazole, imidazole, the triazoles, benzimidazole, indole, piperidine, morpholine, theophylline, nornicotene and their derivatives. In the above basic formula R and R are taken together and represent an organic bridging linkage. The compounds react essentially as secondary amines. These compounds can likewise carry substituents, which under the reaction conditions in contact with epoxide compounds, are inactive or substantially less active than the replaceable hydrogen atom intended for the reaction.
Other suitable starting materials are, for example, straight-chain and cyclic sulfonic acid amides or carboxylic acid amides, which contain one reactive hydrogen atom on the nitrogen atom. To this class, be ong compounds such as p-toluene sulfonic acid methylamide, p-toluene sulfonic acid anilide, p-toluene sulfonic acid dodecylamide, p-toluene sulfonic acid oleylamide, 4- acetamido-benzene-sulfonic acid methylamide, p-acetamido benzene sulfonic acid-N-thiazolylamide, p-nitroacetanilide, p chloroacetanilide, N acetyl-p-toluidine, acetophenetidine, also sultams and lactams. In the above basic formula for amides, R can be selected from the group consisting of alkyl having from 1 to 18 carbon atoms, alkenyl having from 3 to 18 carbon atoms, alkanol having from 2 to 18 carbon atoms, phenyl, halophenyl, lower alkoxyphenyl, nitrophenyl, tetrahydrofurfuryl and thiazolyl; while R can be selected from the group consisting of the acyl of an organic carboxylic acid having from 2 to 18 carbon atoms and the acyl of an organic sulfonic acid having from 2 to 18 carbon atoms. The named and similar compounds may, in turn, carry any other substituents, which, under the reaction conditions, do not react at all or only slowly with epoxide compounds.
Furthermore, straight-chain or cyclic imides such as carboxylic acid-, sulfonic acidor mixed imides are to be considered as, for example, succinimide, phthalimide, maleic acid imide, o-sulfobenzoic acid imide (saccharin); disulfimides such as bis-(p-toluenesulfonyl)-imide, also hydantoin, 5,5-diphenyl-imidazolidine-dione-(2,4), theobromine, and their derivatives. These compounds too can carry substituents, which under the prevailing reaction conditions are either inactive or only slightly active with respect to epoxide compounds.
The triglycidyl isocyanurate, also serving as starting material, can be obtained, according to the processes described in the copending, comonly-assigned US. patent applications Ser. No. 288,593, filed June 18, 1963, now Pat. No. 3,288,789, or Ser. No. 467,140, filed June 25, 1965, now Pat. No. 3,300,490, in a simple manner in pure crystallized form from cyanuric acid and epichlorohydrin. Triglycidyl isocyanurate exists in two diastereomeric forms with difierent melting points (106 C. and 158 C.). Both forms can be employed either each by itself or admixed with each other for the present reaction.
The reaction is effected in that for each one mol of the triglycidyl isocyanurate, three mols of the respective, nitrogen containing compound are reacted. Consequently, it is of advantage to use the reactants at a ratio of about 1:3. Of course, the nitrogen containing compound can also be used in excess, advantageously up to about 6 mols to each mol of triglycidyl isocyanurate. This is particularly advantageous, when the nitrogen containing compound is easily volatile, so that the excess can be removed in a simple manner. It is less advisable to use the nitrogen containing compound in deficiency, because, as a rule,
admixtures of various reaction products are then obtained.
Advantageously, the reaction according to the present invention is carried out in an organic solvent. Suitable are, for example, benzene, toluene, chlorobenzene, dimethylformamide, dimethylsulfoxide, acetone and the like. It was noted that the reaction proceeds faster in polar solvents than in non-polar solvents. However, if the work is carried out with an excess of a basic nitrogen containing compound, no particular consideration is called for in regard to the choice of solvents.
In many cases it is advantageous to accelerate the reaction by adding small amounts of inorganic or organic bases. Suitable bases are, for example, alkali metal hydroxides such as sodium hydroxide and potassium hydroxide; alkali metal lower alkylates such as sodium methylate and sodium ethylate; or tertiary organic bases such as dimethylaniline or dimethylbenzylamine. These compounds are active in relatively small amounts. In general, an addition of 0.001 to 0.1 equivalent of the bases indicated per one mol of the nitrogen containing compound will be sufiicient. However, if the reaction is conducted in those organic solvents, which simultaneously possess protonacceptor properties as, for example, dimethylsulfoxide, anisol, acetophenone, benzophenone, dimethylformamide, benzonitrile and acetonitrile, then a further addition of the above named bases is usually superfluous.
To conduct the reaction according to the invention,
for example, the triglycidyl isocyanurate and the nitrogen containing compound are dissolved in a suitable Organic solvent, and the reaction mixture, if so desired after adding a small amount of a base, is heated until the epoxideoxygen content of the solution has dropped to zero. Frequently it is advantageous to add the base only after the epoxide content has dropped to zero, as otherwise there exists the danger of polymerization of the triglycidyl isocyanurate. The reaction temperature may fluctuate within broad limits, for example, between about 60 C. and 240 C. In many cases it is advantageous to conduct the reaction under the reflux temperature of the organic solvent employed. Inasmuch as the reactants are not apt to decompose at elevated temperatures, the reaction may even be accomplished without any solvents. Moreover, it can be of advantage to add the triglycidyl socyanurate gradually to the dissolved nitrogen containing reactant heated to higher temperatures, as in this way a polymerization of the epoxide can be prevented.
After the reaction is completed, the solvent can be, if so desired, distilled off substantially under decreased pressure. The residue resulting from the evaporation is crystallized with suitable solvents such as alcohol, ether, water and others and, if necesary, recrystallized therefrom. In some cases, an intermediate step can be established 1n the reaction and the cyanurate reaction product converted into the desired oxazolidone in a second operation step. However, in many cases the reaction proceeds so rapidly that the intermediate cannot be isolated.
The following specific embodiments are illustrative of the invention. They are not, however, to be deemed limitative in any respect.
Example 1 15 gm. of the high-melting (,B-form) cyanurate and 20 gm. of diethylamine were stirred together with 200 ml. of nitrobenzene and 0.5 gm. of potassium hydroxide for 5 hours at 150 C. After this period no epoxide-oxygen content was evident any more. Next, the solvent was distilled under decreased pressure. The residue was several times recrystallized from benzin (B.P. C. to C.) with an addition of about 5% of ether. The yield of S-(diethylaminomethyl)-oxazolidone-(2), after five recrystallizations, amounted to 14 gm. (67% of the theory). The product had a melting point of about 70 C.
Analysis.Calculated for C H N O (percent): C,
of triglycidyl iso- 55.8; H, 9.4; N, 16.3. Found (percent): C, 55.4; H, 9.6; N, 15.9.
Example 2 29.7 gm. of the high-melting (B-form) of triglycidyl isocyanurate and 64.2 gm. of methylaniline were stirred together with 400 ml. of nitrobenzene and 0.5 gm. of sodium hydroxide over a period of hours at 150 C. After this time, no epoxide-oxy-gen content was evident anymore. Then the solvent was distilled therefrom under decreased pressure. The resultant residue consisted of a viscous syrup, the oxazolidone structure of which was determined by infra-red-analysis. A sample of 20 gm. was recrystallized five times from an ether/petroleum ether mixture. The melting point of the thus purified 5- [(N-methyl-N-phenyl) -aminomethyl] oxazolidone (2) was 73 C. The yield amounted to 12 gm. corresponding with 59% of the theory.
Analysis.-Calculated for C H N O (percent): C, 64.1; H, 6.8; N, 13.6; M.W., 206. Found (percent): C, 64.2; H, 6.9; N, 13.2; M.W., 191.
Example 3 30 gm. of the high-melting (p-form) of triglycidyl isocyanurate were heated together with 81 gm. of pnitroacetanilide and 300 ml. of dimethylforamide to 140 C. while stirring. 0.5 gm. of sodium hydroxide were added to the mixture. After a reaction period of 4 hours at 140 C., the epoxide-oxygen content of the solution had dropped to zero. After being cooled to room temperature, the solvent was distilled therefrom, to a great extent, under decreased pressure. The resultant residue (111 gm.) was extracted twice with water. After concentration of the aqueous phase, a residue remained, which was recrystallized twice from ethanol.
The yield in N-(p-nitrophenyl)-N-[(oxazolidone-(2)- yl-(5))-methyl]-acetamide amounted to 56 gm. corresponding with 68% of the theory. The substance started to sinter at a temperature of 177 C. and was completely melted at 181 C.
Analysis.-Calculated for C H N O (percent): C, 51.6; H, 4.7; N, 15.1; M.W., 279. Found (percent): C, 52.0; H, 5.1; N, 15.0; M.W., 269.
Example 4 29.7 gm. of the low-melting (or-form) of triglycidyl isocyanurate and 44.5 gm. of phthalimide were heated together with 400 ml. of chlorobenzene and 200 mg. of sodium hydroxide at reflux for 1% hours. After this period no epoxide-oxygen content was evident anymore. Subsequently, most of the solvent was distilled 01f at decreased pressure. The residue was recrystallized from a water/ethanol mixture (1:1). 65 gm., that is 88% of theory, of S-(phthalimidomethyl)-oxazolidone-(2) were obtained, the product having a melting point of 184 C.
Analysis.Calculated for C H N O (percent): C, 58.5; H, 4.1; N, 11.4; M.W., 246. Found (percent): C, 58.7; H, 4.1; N, 11.0; M.W., 244.
Example '5 29.7 gm. of the high-melting (fit-form) of triglycidyl isocyanurate and 5 6 gm. of p-toluenesulfonic acid methylamide were heated, together with 500 ml. of toluene and 300 mg. of pulverized sodium hydroxide, at reflux for 5 hours. After this period, the epoxide-oxygen content of the solution had dropped to zero. Then most of the solvent was distilled off under decreased pressure (water-jet pump). The residue was recrystallized from benezene. 70 gm. (that is 82% of theory) of N-methyl- N [(oxazolidone-(2)-yl-(5))-methyl] p toluene-sulfonamide were obtained. The product had a melting point of 121 C.
Analysis-Calculated for C H N O S (percent): N, 9.9; S, 11.2; M.W., 284. Found (percent): N, 10.2; S, 11.0; M.W., 307.
6 Example 6 29.7 gm. of the high-melting (pr-form) of triglycidyl isocyanurate and 55 gm. of saccharin (2,3-dihydro-3- oxobenzisosulfonazole) were heated, together with one liter of chlorobenzene and 300 mg. of sodium hydroxide, at reflux. After 14 hours the epoxide-oxygen content of the solution had dropped to zero. Thereafter, most of the solvent was distilled off under decreased pressure, the residue was taken up in chloroform and precipitated with ether.
After triple reprecipitation, the yield of N-([oxazolidone-(2)-yl-(5)]-methyl)-saccharin amounted to 40 gm. (47.5% of the theory). The product obtained had a melting point of 136 C.
Analysis.--Calculated for C H N O S (percent): N, 9.9%; S, 11.3. Found (percent): N, 9.8; S, 11.0.
Example 7 29.7 gm. of the low-melting (ct-form) of triglycidyl isocyanurate and 28 gm. of piperidine were heated, together with 350 m1. of toluene and 250 mg. of sodium hydroxide for 1 hour at reflux. After this time the epoxideoxygen content had dropped to zero. The purification of the mixture was effected by recrystallization of the evaporation residue from ethyl acetate.
The yield of the S-piperidinomethyl-oxazolidone-(2), having a melting point of 114 C., amounted to 48 gm. (87% of the theory).
Analysis.Calculated for C H N O (percent): C, 58.7; H, 8.7; N, 15.2; M.W., 184. Found (percent): C, 59.0; H, 8.8; N, 14.9; M.W., 183.
Example 8 29.7 gm. of the low-melting (or-form) of triglycidyl isocyanurate and 27 gm. of morpholine were heated, together with 350 ml. of toluene and 250 mg. of sodium hydroxide, at reflux for 1 hour. After this period of time no epoxide-oxygen content was evident anymore. The purification of the mixture was effected by a single recrystallization of the precipitation product from toluene. The yield of 5 morpholinomethyl oxazolidone (2) amounted to 52 gm. (92% of the theory). The product had a melting point of 124 C.
Analysis.Calculated for C H N O (percent): C, 51.6; H, 7.6; N, 15.0; M.W., 186. Found (percent): C, 51.6; H, 7.7; N, 15.1; M.W., 176.
Example 9 This example proves that it is often possible to isolate the adduct formed in the first step by means of reaction of the nitrogen containing compound with triglycidyl isocyanurate, and then, in a second step to effect the cyclization to oxazolidone with the addition of a base.
29.7 gm. of triglycidyl isocyanurate (fl-form) were heated, together with 27 gm. of morpholine, for 3 hours at reflux in 300 ml. of toluene. After this time the test for epoxide-oxygen content was negative. While the reaction solution was cooling, a crystalline precipitate formed, which, after being filtered and Washed once with cold toluene, had a melting point of 168 C. The yield in tris (2-hydroxy-3-N-morpholine-propyl) isocyanurate amounted to 54 gm. (96% of the theory).
This isocyanurate was again heated, in a second reaction stage, at reflux for 10 hours in 300 ml. of toluene, in the presence of 30 mg. of sodium hydroxide. After the reaction mixture had been cooled, the crystallized 5- morpholino-methyl-oxazolidone-(2) was filtered and re crystallized from benzene. The product, which was identical to the one obtained by the process described in Example 8, had a melting point of 124 C. The yield amounted to 43 gm. of product (75% of the theory).
Example 10 29.7 gm. of the high-melting (ii-form) of triglycidyl isocyanurate and 50.0 gm. of di-n-butylamine were heated together with 500 ml. of chlorobenzene 500 mg. of sodium hydroxide at reflux for 7 hours. After this period no epoxide-oxygen content was evident anymore. After being cooled to room temperature the reaction solution was filtered and the solvent was distilled therefrom under decreased pressure. The residue was crude S-(di-n-butylaminomethyl)-oxaZolidone-(2) in a yield of 59 gm. (86% of the theory). After distillation under decreased pressure the yield of the pure product amounted to 51 gm. (74.6% of the theory). The product obtained had a boiling point of 161 C. at a pressure of 0.2 torrv Analysis.Calcu-lated for C H N O (percent): C, 63.1; H, 10.5; N, 12.3. Found (percent): C, 63.4; H, 10.7; N, 12.0.
The products obtained according to the process of the invention are valuable pharmaceutics.
The invention process renders it possible to combine the pharmacologically active oxazolidone group in a very careful way with other pharmacologically active groups, for example with the sulfonamide groups to obtain the combined pharmacological eifectiveness of both active groups.
The advantage, which is obtainable on hand of the invention, consists in particular in that accordingly oxazolidones can be prepared from those reactants, which are thermically sensitive as for example morpholine, and for which other oxazolidone syntheses fail for this very reason.
The products produced are useful as sedatives and muscular relaxants, in general at low dosages.
The preceding specific embodiments are illustrative of the practice of the invention. It is to be understood however that other expedient, as would occur to those skilled in the art, may be employed without departing from the spirit of the invention.
I claim:
1. A process for the production of a -substituted oxa- Zolidone of the formula wherein R is selected from the group consisting of alkyl having from 1 to 18 carbon atoms, alkenyl having from 3 to 18 carbon atoms, hydroxyalkyl having from 2 to 18 carbon atoms, phenyl, halophenyl, lower alkoxyphenyl, nitrophenyl and tetrahydrofurfuryl and R is selected from the group consisting of alkyl having from 1 to 18 carbon atoms, alkenyl having from 3 to 18 carbon atoms, hydroxyalkyl having from 2 to 18 carbon atoms, phenyl, halophenyl, lower alkoxyphenyl, nitrophenyl alkanoyl having from 2 to 18 carbon atoms and arylsulfonyl having from 7 to 18 carbon atoms, and where R and R taken togteher with the nitrogen atom, are selected from the group consisting of pyrrolidinyl, piperidinyl, morpholinyl, arylene dicarboxylic acid imdo arylene dsulfonic acid imido and arylene mono-carboxylic acid-mono-sulfonic acid mixed imido; where R and R have a total of from 4 to 30 carbon atoms, which comprises reacting triglycidyl isocyanurate wth a compound of the formula wherein R and R have the above-assigned values and H represents a hydrogen atom capable of reacting with an epoxide compound, at a temperature between about 60 C. and about 240 C., and recovering said 5-substituted oxazolidone.
2. The process of claim 1 wherein said reaction is conducted in the presence of an organic solvent.
3. The process of claim 2 wherein said organic solvent is a proton acceptor.
4. The process of claim 1 wherein said reaction is conducted in the presence of small amounts of bases selected from the group consisting of inorganic bases and tertiary organic bases.
5. The process of claim 1 wherein from 3 to 6 mols of the compound are employed per mol of triglycidyl isocyanurate. 6. A S-substituted oxazolidone of the formula CH2NH wherein R is selected from the group consisting of alkyl having from 1 to 18 carbon atoms, alkenyl having from 3 to 18 carbon atoms, hydroxyalkyl having from 2 to 18 carbon atoms, phenyl, halophenyl, lower alkoxyphenyl, nitrophenyl and tetrahydrofurfuryl and R is selected from the group consisting of alkyl having from 1 to 18 carbon atoms, alkenyl having from 3 to 18 carbon atoms, hydroxyalkyl having from 2 to 18 carbon atoms, phenyl, halophenyl, lower alkoxyphenyl, nitrophenyl, alkanoyl having from 2 to 18 carbon atoms and arylsulfonyl having from 7 to 18 carbon atoms, and where R and R taken together with the nitrogen atom, are selected from the group consisting of pyrrolidinyl, piperidinyl, morpholinyl, arylene dicarboxylic acid imido, arylene disulfonic acid imido and arylene mono-carboxylic acid-mono-sulfonic acid mixed imido; where R and R have a total of from 4 to 30 carbon atoms.
7. The process of claim 6 wherein R and R are butyl.
8. The process of claim 6 wherein R is methyl and R is phenyl.
9. The process of claim 6 wherein R is p-nitrophenyl and R is acetyl.
10. The process of claim 6 wherein R is methyl and R is p-toluene sulfonyl.
11. The process of claim 6 wherein R and R taken together with the nitrogen atom is piperidinyl.
12. The process of claim 6 wherein R and R taken together with the nitrogen atom is morpholinyl.
13. The process of claim 6 wherein R and R taken together with the nitrogen atom is phthalimido.
14. The process of claim 6 wherein R and R taken together with the nitrogen atom is o-sulfobenzoylimido.
References Cited UNITED STATES PATENTS 3,108,115 10/1963 Little et al 260-307 3,231,577 l/1966 Walles 260-307 FOREIGN PATENTS 1,085,106 9/1967 Great Britain.
OTHER REFERENCES Weissberger: The Chemistry of Heterocyclic Compounds, vol. 19, Part one (Interscience, N.Y., 1964), pages 316-318.
ALTON D. ROLLlNS, Primary Examiner U.S. Cl. X.R.
US566214A 1966-06-24 1966-07-19 Process for the preparation of substituted oxazolidones Expired - Lifetime US3528976A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1076965A CH475242A (en) 1966-06-24 1966-06-24 Process for the production of aromatic ethers
DEH0059753 1966-06-24

Publications (1)

Publication Number Publication Date
US3528976A true US3528976A (en) 1970-09-15

Family

ID=25707254

Family Applications (2)

Application Number Title Priority Date Filing Date
US566214A Expired - Lifetime US3528976A (en) 1966-06-24 1966-07-19 Process for the preparation of substituted oxazolidones
US39505A Expired - Lifetime US3706755A (en) 1966-06-24 1970-05-21 Certain 4(3-(4-(phenyl)-3,6-dihydro-1(2h)pyridyl)-2 - hydroxy-propoxy)-benzophenones

Family Applications After (1)

Application Number Title Priority Date Filing Date
US39505A Expired - Lifetime US3706755A (en) 1966-06-24 1970-05-21 Certain 4(3-(4-(phenyl)-3,6-dihydro-1(2h)pyridyl)-2 - hydroxy-propoxy)-benzophenones

Country Status (11)

Country Link
US (2) US3528976A (en)
BE (1) BE684600A (en)
BR (1) BR6681621D0 (en)
CH (1) CH479603A (en)
DE (2) DE1695146A1 (en)
FR (1) FR6263M (en)
GB (2) GB1085106A (en)
IL (1) IL26198A (en)
NL (2) NL6610566A (en)
NO (1) NO121212B (en)
SE (1) SE322775B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698565A (en) * 1995-06-09 1997-12-16 Hoffmann-La Roche Inc. Use of phenoxy-pyridine derivatives

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL133317C (en) * 1966-06-24 1900-01-01
US3879405A (en) * 1970-06-19 1975-04-22 Hoffmann La Roche Tetrahydropyridine derivatives
US3951987A (en) * 1970-06-19 1976-04-20 Hoffmann-La Roche Inc. Tetrahydropyridine derivatives
US3927006A (en) * 1970-06-19 1975-12-16 Hoffmann La Roche Tetrahydropyridine derivatives
US5182296A (en) * 1989-10-26 1993-01-26 Tanabe Seiyaky Co., Ltd. Naphthyloxazolidone derivatives
WO2003106413A2 (en) * 2001-10-18 2003-12-24 Michigan State University Process for the preparation of oxazolidinones and method of use thereof
JP2010503763A (en) * 2006-09-18 2010-02-04 スターファイアー システムズ， インコーポレイテッド Process for preparing siloxane-based composition and derivative composition thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3108115A (en) * 1959-10-23 1963-10-22 Allied Chem Production of 2-oxazolidones
US3231577A (en) * 1960-07-25 1966-01-25 Dow Chemical Co Production of oxazolidinones
GB1085106A (en) * 1966-06-24 1967-09-27 Henkel & Cie Gmbh Process for the preparation of substituted oxazolidones

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3108115A (en) * 1959-10-23 1963-10-22 Allied Chem Production of 2-oxazolidones
US3231577A (en) * 1960-07-25 1966-01-25 Dow Chemical Co Production of oxazolidinones
GB1085106A (en) * 1966-06-24 1967-09-27 Henkel & Cie Gmbh Process for the preparation of substituted oxazolidones

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698565A (en) * 1995-06-09 1997-12-16 Hoffmann-La Roche Inc. Use of phenoxy-pyridine derivatives

Also Published As

Publication number Publication date
NL6610566A (en) 1967-01-31
DE1695146A1 (en) 1970-12-17
SE322775B (en) 1970-04-20
BR6681621D0 (en) 1973-12-27
GB1085106A (en) 1967-09-27
DE1695148A1 (en) 1970-12-17
NO121212B (en) 1971-02-01
GB1111917A (en) 1968-05-01
US3706755A (en) 1972-12-19
IL26198A (en) 1970-10-30
CH479603A (en) 1969-10-15
NL133317C (en) 1900-01-01
FR6263M (en) 1968-08-26
BE684600A (en) 1967-01-26

Similar Documents

Publication Publication Date Title
US3681330A (en) 2,3-dihydro-1,4-benzoxazines
EP1503993A2 (en) Compounds, methods and compositions
US3196153A (en) Poly(3, 5-diketo-piperazinyl-1) compounds
US3528976A (en) Process for the preparation of substituted oxazolidones
US3394143A (en) Heterocycleethanols
US3862955A (en) Process for the preparation of 1,2-benzisothiazolin 3-ones
US2852525A (en) Novel chemical compounds
US3458528A (en) Nitroimidazole carbonates and thionocarbonates
FI61309C (en) FOERFARANDE FOER FRAMSTAELLNING AV NYA PSYKOSEDATIVA OCH ANTIKONVULSIVA 5-PHENYL-1H-1,5-BENZODIAZEPIN-2,4-DIONER
WO2004100873A2 (en) Compounds, compositions, and methods
CA1154015A (en) Tetrahydroquinoline derivatives, a process for their preparation, their use, and pharmaceutical formulations containing them
CA1107285A (en) Arylaminoimidazoline derivatives and the preparation thereof
US3423421A (en) Substituted dihydro-11h-isoindolo(2,1-a) benzimidazol - 11 - ones and related compounds
Nagai et al. On the behavior of sulfonyl imide as a reactive intermediate. The reaction with enamines.
US3328403A (en) 3-phenyl substituted-1-acetamidopyridazone derivatives and their preparation
US3296251A (en) 3-mercapto and 3-substituted mercapto-1, 3-dihydro-2h-1, 4-benzodiazepin-2-ones
US3795673A (en) Process for producing benzodiazepine derivatives
US3560517A (en) Isoxazolidine carboxanilides
US3523119A (en) Process of producing pyrimidine-5-carboxylic acid with a basic substituent in the 4-position
US3536725A (en) Cyanoethylated derivatives of 2,3,4,6,7,12-hexahydroindolo(2,3-alpha)-quinolizine
US3328416A (en) Certain 2-(substituted hydrazino)-2-thiazolines
US3293252A (en) Benzazaborinone derivatives and related compounds
Bosc et al. New investigation of the reaction of 2-amino-2-oxazolines with isocyanates and isothiocyanates. Evidence of a transposition during the second step
US2774756A (en) New triazine compounds and process of making them
US2323391A (en) Beta-amino acid amides and method of making same